Save big on your family healthcare expenses. Become a myUpchar plus member only at Rs. 99 -

Lamivudine

Lamivudine Information

Lamivudine Benefits & Uses

Lamivudine is used to treat the following -

Lamivudine Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Log in to view medicine dosage

Ingredients of Lamivudine

Lamivudine

Lamivudine Side Effects

Based on research, the following side effects have been observed when Lamivudine is used -

  1. Fatigue Mild
  2. Headache Mild
  3. Nausea or vomiting
  4. Abdominal Pain Mild
  5. Dizziness Mild
  6. Muscle Ache Mild
  7. Diarrhoea
  8. Anemia Moderate
  9. Fever Mild
  10. Cough Mild
  11. Rash
  12. Infection
  13. Nasal congestion

Lamivudine Related Warnings

Is the use of Lamivudine safe for pregnant women?

Pregnant women may experience moderate side effects from Lamivudine. It is best to stop taking Lamivudine immediately and inform your doctor if you notice any discomfort.

Moderate

Is the use of Lamivudine safe during breastfeeding?

Women who are breastfeeding can experience some moderate side effects of Lamivudine. Immediately discontinue Lamivudine if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.

Moderate

What is the effect of Lamivudine on the Kidneys?

Lamivudine has very mild side effects on the kidneys.

Mild

What is the effect of Lamivudine on the Liver?

Lamivudine is rarely harmful for the liver.

Mild

What is the effect of Lamivudine on the Heart?

Lamivudine is not harmful for the heart.

Safe

Severe Interaction of Lamivudine with Other Drugs

Lamivudine should not be taken with following medicines due to severe side effects it may cause to patients -

Adefovir

Emtricitabine,Tenofovir,Efavirenz

    Sulfamethoxazole,Trimethoprim

      Lamivudine Contraindications

      If you are suffering from any of the following diseases, you should not take Lamivudine unless your doctor advises you to do so -

      1. Liver Disease
      2. Kidney Disease
      3. Diabetes
      4. Graves' Disease
      5. Guillain-Barre Syndrome
      6. Pancreatitis

      Frequently asked Questions about Lamivudine

      Is this Lamivudine habit forming or addictive?

      No, there is no any evidence that Lamivudine is addictive.

      No

      Is it safe to drive or operate heavy machinery when consuming?

      Yes, you can operate a vehicle or heavy machinery after taking Lamivudine since it does not cause drowsiness.

      Safe

      Is it safe?

      Yes, but take Lamivudine only as per medical advice.

      Safe, but take only on Doctor's advise

      Is it able to treat mental disorders?

      No, the use of Lamivudine in mental disorders is not effective.

      No

      Lamivudine Interactions with Food and Alcohol

      Interaction between Food and Lamivudine

      Taking Lamivudine with food does not harm your health.

      Safe

      Interaction between Alcohol and Lamivudine

      Consumption of alcohol and Lamivudine together may have severe effects on your health.

      Severe
      This medicine data has been created by -
      Dr. Md Saadullah
      M.Pharma, Pharmacy
      3 Years of Experience
      View Doctor Profile
      Dr. Vikas Chauhan
      B.Pharma, Pharmacy
      2 Years of Experience
      View Doctor Profile

      Do you or someone in your family take Lamivudine? Please do a survey and help others

      References

      1. US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
      2. KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
      3. April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99